ANXA1 and cancer: The comparative analysis of tumor tissues and adjacent margins has also shown a stronger ANXA1 expression in cancer samples (p = 0.0001), in correlation with elevated CEA serum levels (p = 0.004), suggesting that ANXA1 may play a key promoter role in CRC aggressiveness and disease progression [21].